Índice Bovespa

US Dollar vs BRL

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

HUGE FSD Pharma Inc

0,2991

-0,0109 (-3,52%)

31 Mai 2024 - Fechado

Atrasado em 15 minutos

Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]

nullnull

FSD Pharma (NASDAQ:HUGE)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024

Click aqui para mais gráficos FSD Pharma.

FSD Pharma (NASDAQ:HUGE)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024

Click aqui para mais gráficos FSD Pharma.

Notícias FSD Pharma Inc

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Sexta, 31 de Maio de 2024 (1 dia atrás) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Terça, 20 de Fevereiro de 2024 (3 meses atrás) • Edgar (US Regulatory)

GBB Maintains Strong Position in its Ongoing Lawsuit with FSD Pharma After Court Refuses to Dismiss Case
Quinta, 11 de Janeiro de 2024 (5 meses atrás) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Sexta, 5 de Janeiro de 2024 (5 meses atrás) • Edgar (US Regulatory)

InvestmentPitch Media Video Discusses FSD Pharma’s Continued Development of its Exciting New Rapid Detox Drink UNBUZZD™, with Video Comments from Kevin Harrington
Sexta, 22 de Setembro de 2023 (8 meses atrás) • GlobeNewswire Inc.

FSD Pharma Rebuts Claims of GBB Drink Lab now acquired by Jupiter Wellness Inc. Trading under the symbol (NASDAQ: JUPW)
Sexta, 25 de Agosto de 2023 (9 meses atrás) • Business Wire

InvestmentPitch Media Video Features FSD Pharma’s Definitive Agreement Granting Exclusive Rights for Launch of UNBUZZD, a Revolutionary Rapid Alcohol Detoxification Drink
Quinta, 3 de Agosto de 2023 (10 meses atrás) • GlobeNewswire Inc.

Arbitration Panel Finds that Syneos Health (NASDAQ: SYNH) Failed to Use Commercially Reasonable Efforts in Conducting its Trial for FSD 201
Segunda, 17 de Julho de 2023 (11 meses atrás) • Business Wire

FSD Pharma Retains Christian Attar Law and Team of Experts to Lead Preliminary Investigation of Possible Naked Short Selling and Manipulation in its stock
Segunda, 10 de Julho de 2023 (11 meses atrás) • Business Wire

FSD Pharma Appoints Zeeshan Saeed as Chief Executive Officer, Anthony Durkacz to Serve as Executive Co-Chairman of the Board of Directors
Terça, 4 de Julho de 2023 (11 meses atrás) • Business Wire

FSD Pharma Inc. Announces Results of Annual General and Special Meeting of Shareholders
Sexta, 30 de Junho de 2023 (11 meses atrás) • Business Wire

InvestmentPitch Media Video Discusses FSD Pharma’s Granting of Exclusive Rights to Revolutionary Recreational Alcohol Misuse Technology to Celly Nutrition
Sexta, 23 de Junho de 2023 (11 meses atrás) • GlobeNewswire Inc.

Mais Notícias de FSD Pharma Inc

Índice Bovespa

MAGAZINE LUIZA ON

PÃO DE AÇUCAR ON

CM Hospitalar ON

Blau Farmaceutica ON

TRIUNFO PART ON

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições